Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LY-4101174 by Eli Lilly and Co for Cervical Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Cervical Cancer. According to...
LY-4101174 by Eli Lilly and Co for Prostate Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Prostate Cancer. According to...
LY-4101174 by Eli Lilly and Co for Ovarian Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to...
LY-4101174 by Eli Lilly and Co for Esophageal Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Esophageal Cancer. According to...
LY-4101174 by Eli Lilly and Co for Non-Small Cell Lung Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Non-Small Cell Lung Cancer....
LY-4101174 by Eli Lilly and Co for Pancreatic Cancer: Likelihood of Approval
LY-4101174 is under clinical development by Eli Lilly and Co and currently in Phase I for Pancreatic Cancer. According to...